These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 25175088)

  • 1. Endothelial (dys)function in lone atrial fibrillation.
    Polovina MM; Lip GY; Potpara TS
    Curr Pharm Des; 2015; 21(5):622-45. PubMed ID: 25175088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble E-selectin, von Willebrand factor, soluble thrombomodulin, and total body nitrate/nitrite product as indices of endothelial damage/dysfunction in paroxysmal, persistent, and permanent atrial fibrillation.
    Freestone B; Chong AY; Nuttall S; Blann AD; Lip GY
    Chest; 2007 Oct; 132(4):1253-8. PubMed ID: 17890461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired flow mediated dilatation as evidence of endothelial dysfunction in chronic atrial fibrillation: relationship to plasma von Willebrand factor and soluble E-selectin levels.
    Freestone B; Chong AY; Nuttall S; Lip GY
    Thromb Res; 2008; 122(1):85-90. PubMed ID: 17996280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of atrial fibrillation on plasma von willebrand factor, soluble E-selectin, and N-terminal pro B-type natriuretic peptide levels in systolic heart failure.
    Freestone B; Gustafsson F; Chong AY; Corell P; Kistorp C; Hildebrandt P; Lip GY
    Chest; 2008 May; 133(5):1203-8. PubMed ID: 18339785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of plasma von Willebrand factor and soluble P-selectin as indices of endothelial damage and platelet activation in 994 patients with nonvalvular atrial fibrillation.
    Conway DS; Pearce LA; Chin BS; Hart RG; Lip GY
    Circulation; 2003 Jul; 107(25):3141-5. PubMed ID: 12796127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic role of plasma von Willebrand factor and soluble E-selectin levels for future cardiovascular events in a 'real-world' community cohort of patients with atrial fibrillation.
    Krishnamoorthy S; Khoo CW; Lim HS; Lane DA; Pignatelli P; Basili S; Violi F; Lip GY
    Eur J Clin Invest; 2013 Oct; 43(10):1032-8. PubMed ID: 23961715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating progenitor cells in patients with atrial fibrillation and their relation with serum markers of inflammation and angiogenesis.
    Watson T; Shantsila E; Blann A; Lip GY
    Thromb Haemost; 2010 Aug; 104(2):327-34. PubMed ID: 20508899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased von Willebrand factor in the endocardium as a local predisposing factor for thrombogenesis in overloaded human atrial appendage.
    Fukuchi M; Watanabe J; Kumagai K; Katori Y; Baba S; Fukuda K; Yagi T; Iguchi A; Yokoyama H; Miura M; Kagaya Y; Sato S; Tabayashi K; Shirato K
    J Am Coll Cardiol; 2001 Apr; 37(5):1436-42. PubMed ID: 11300458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma von Willebrand factor, soluble thrombomodulin, and fibrin D-dimer concentrations in acute onset non-rheumatic atrial fibrillation.
    Marín F; Roldán V; Climent VE; Ibáñez A; García A; Marco P; Sogorb F; Lip GY
    Heart; 2004 Oct; 90(10):1162-6. PubMed ID: 15367514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating endothelial cells in atrial fibrillation with and without acute cardiovascular disease.
    Freestone B; Lip GY; Chong AY; Nadar S; Lee KW; Blann AD
    Thromb Haemost; 2005 Oct; 94(4):702-6. PubMed ID: 16270620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of direct current cardioversion for persistent atrial fibrillation on indices of endothelial damage/dysfunction.
    Freestone B; Chong AY; Blann AD; Lip GY
    Thromb Res; 2006; 118(4):479-85. PubMed ID: 16318868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of plasma von Willebrand factor levels, an index of endothelial damage/dysfunction, with two point-based stroke risk stratification scores in atrial fibrillation.
    Roldán V; Marín F; García-Herola A; Lip GY
    Thromb Res; 2005; 116(4):321-5. PubMed ID: 16038717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma von Willebrand factor and soluble p-selectin as indices of endothelial damage and platelet activation in 1321 patients with nonvalvular atrial fibrillation: relationship to stroke risk factors.
    Conway DS; Pearce LA; Chin BS; Hart RG; Lip GY
    Circulation; 2002 Oct; 106(15):1962-7. PubMed ID: 12370220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between left atrial size, prothrombotic state and markers of endothelial dysfunction in patients with lone chronic nonrheumatic atrial fibrillation.
    Mondillo S; Sabatini L; Agricola E; Ammaturo T; Guerrini F; Barbati R; Pastore M; Fineschi D; Nami R
    Int J Cardiol; 2000 Sep; 75(2-3):227-32. PubMed ID: 11077138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma von Willebrand factor, fibrinogen and soluble P-selectin levels in paroxysmal, persistent and permanent atrial fibrillation. Effects of cardioversion and return of left atrial function.
    Li-Saw-Hee FL; Blann AD; Gurney D; Lip GY
    Eur Heart J; 2001 Sep; 22(18):1741-7. PubMed ID: 11511124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progressive endothelial damage revealed by multilevel von Willebrand factor plasma concentrations in atrial fibrillation patients.
    Scridon A; Girerd N; Rugeri L; Nonin-Babary E; Chevalier P
    Europace; 2013 Nov; 15(11):1562-6. PubMed ID: 23689486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombomodulin, von Willebrand factor and E-selectin as plasma markers of endothelial damage/dysfunction and activation in pregnancy induced hypertension.
    Nadar SK; Al Yemeni E; Blann AD; Lip GY
    Thromb Res; 2004; 113(2):123-8. PubMed ID: 15115667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating endothelial cell markers in peripheral vascular disease: relationship to the location and extent of atherosclerotic disease.
    Blann AD; Seigneur M; Steiner M; Boisseau MR; McCollum CN
    Eur J Clin Invest; 1997 Nov; 27(11):916-21. PubMed ID: 9395787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atrial fibrillation and hypercoagulability: dependent on clinical factors or/and on genetic alterations?
    Hatzinikolaou-Kotsakou E; Kartasis Z; Tziakas D; Hotidis A; Stakos D; Tsatalas K; Bourikas G; Kotsakou ME; Hatseras DI
    J Thromb Thrombolysis; 2003 Dec; 16(3):155-61. PubMed ID: 15087601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship of indices of inflammation and thrombogenesis to arrhythmia burden in paroxysmal atrial fibrillation.
    Watson T; Arya A; Sulke N; Lip GY
    Chest; 2010 Apr; 137(4):869-76. PubMed ID: 19858230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.